Researchers have developed a novel compound that could transform the way we treat Alzheimer's disease, offering not just a ...

A new study has found that combining the current medications for Alzheimer's disease with small molecules derived from ...

In Alzheimer’s disease, brain damage is often linked to a mix of problems, including beta-amyloid buildup, tau pathology, ...

NeuroTherapia has concluded its Phase IIa clinical trial of NTRX-07, an orally available molecule, for Alzheimer's disease ...

I understand that there is treatment for the beginning stages of Alzheimer’s disease that can stave off serious decline. There are also new tests to determine if a person is in the beginning stages, ...

Autopsy shows widespread amyloid and tau in patient who received contaminated biological m ...

Alzheimer’s isn’t just one problem—it’s a tangled mix of biology, aging, and overall health. That’s why drugs targeting a single factor have fallen short, even as new treatments show modest benefits.

The Alzheimer’s Association offers resources to people diagnosed with Alzheimer’s, as well as loved ones and caretakers. The organization helps patients locate a doctor who fits their needs, provides ...

The experimental drug lecanemab shows "potential" as an Alzheimer's disease treatment, according to new Phase 3 trial results, but the findings raise some safety concerns because of its association ...

Is Alzheimer’s disease a public health crisis yet? Now? Certainly yes for far too many families, but if not today for society in general, the wait will be brief. The Chicago Tribune carried an opinion ...

A new study suggests that a hormone therapy harvested from human corpses may be linked to a rare, controversial form of ...

Losing your sense of smell might signal Alzheimer’s far earlier than expected. Scientists found that immune cells in the brain actively destroy smell-related nerve fibers after detecting abnormal ...